Total Payments
$583,528
2024 Payments
$47,076
Companies
67
Transactions
1,176
Medicare Patients
23,549
Medicare Billing
$2.7M
Payment Breakdown by Category
Other$365,236 (62.6%)
Consulting$146,289 (25.1%)
Travel$48,299 (8.3%)
Food & Beverage$22,615 (3.9%)
Education$1,088 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $294,203 | 164 | 50.4% |
| Consulting Fee | $146,289 | 79 | 25.1% |
| Honoraria | $53,433 | 27 | 9.2% |
| Travel and Lodging | $48,299 | 141 | 8.3% |
| Food and Beverage | $22,615 | 745 | 3.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $17,600 | 4 | 3.0% |
| Education | $1,088 | 16 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $122,764 | 176 | $0 (2024) |
| Janssen Biotech, Inc. | $81,506 | 147 | $0 (2024) |
| Amgen Inc. | $54,355 | 96 | $0 (2022) |
| PFIZER INC. | $34,429 | 102 | $0 (2024) |
| Astellas Pharma US Inc | $33,656 | 95 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $27,308 | 50 | $0 (2024) |
| UROGEN PHARMA, INC. | $25,598 | 29 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $25,097 | 23 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $24,522 | 30 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $22,223 | 40 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,076 | 116 | Janssen Biotech, Inc. ($8,230) |
| 2023 | $67,136 | 143 | Janssen Biotech, Inc. ($12,314) |
| 2022 | $72,790 | 131 | UroGen Pharma, Inc. ($14,945) |
| 2021 | $64,519 | 87 | Dendreon Pharmaceuticals LLC ($17,223) |
| 2020 | $56,821 | 66 | Dendreon Pharmaceuticals LLC ($14,983) |
| 2019 | $98,853 | 232 | Janssen Biotech, Inc. ($35,197) |
| 2018 | $75,070 | 181 | Dendreon Pharmaceuticals LLC ($28,375) |
| 2017 | $101,263 | 220 | Dendreon Pharmaceuticals LLC ($43,807) |
All Payment Transactions
1,176 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 12/18/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: OS | ||||||
| 12/13/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: HORMONE THERAPY | ||||||
| 12/10/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $880.00 | General |
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $157.50 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: UROLOGY | ||||||
| 12/02/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: HORMONE THERAPY | ||||||
| 11/21/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $25.09 | General |
| 11/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $116.71 | General |
| Category: Oncology | ||||||
| 11/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $164.57 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/13/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug), AKEEGA, PIPELINE | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/05/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: HORMONE THERAPY | ||||||
| 11/01/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $36.01 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/18/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Oncology | ||||||
| 10/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 5,168 | 16,126 | $1.1M | $487,326 |
| 2022 | 54 | 5,391 | 19,316 | $1.2M | $563,878 |
| 2021 | 60 | 6,605 | 26,473 | $1.7M | $831,303 |
| 2020 | 63 | 6,385 | 31,585 | $1.8M | $797,811 |
Total Patients
23,549
Total Services
93,500
Medicare Billing
$2.7M
Procedure Codes
226
All Medicare Procedures & Services
226 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 680 | 1,069 | $153,430 | $99,888 | 65.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 21 | 4,500 | $107,280 | $81,111 | 75.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 50 | 396 | $277,200 | $53,337 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 517 | 657 | $69,255 | $44,092 | 63.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 146 | 179 | $72,800 | $33,989 | 46.7% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 98 | 103 | $59,330 | $30,176 | 50.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 68 | 421 | $29,470 | $20,460 | 69.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 579 | 766 | $26,810 | $13,752 | 51.3% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 15 | 3,440 | $13,948 | $10,922 | 78.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 154 | 281 | $39,593 | $10,854 | 27.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 73 | 73 | $21,900 | $7,741 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $13,050 | $7,105 | 54.4% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 12 | 12 | $45,600 | $6,968 | 15.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 62 | $10,230 | $6,725 | 65.7% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 324 | 367 | $13,946 | $6,573 | 47.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 85 | $8,500 | $5,582 | 65.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 48 | 59 | $5,900 | $3,944 | 66.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 19 | 19 | $9,500 | $3,810 | 40.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 953 | 1,729 | $10,374 | $3,787 | 36.5% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 81 | 141 | $6,345 | $3,566 | 56.2% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 12 | 13 | $9,100 | $3,440 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 58 | 58 | $4,060 | $2,560 | 63.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 19 | 28 | $25,200 | $2,360 | 9.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $3,770 | $2,238 | 59.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $2,865 | $2,065 | 72.1% |
About Dr. Jason Hafron, MD
Dr. Jason Hafron, MD is a Urology healthcare provider based in West Bloomfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255483277.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Hafron, MD has received a total of $583,528 in payments from pharmaceutical and medical device companies, with $47,076 received in 2024. These payments were reported across 1,176 transactions from 67 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($294,203).
As a Medicare-enrolled provider, Hafron has provided services to 23,549 Medicare beneficiaries, totaling 93,500 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 226 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location West Bloomfield, MI
- Active Since 01/18/2007
- Last Updated 10/22/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1255483277
Products in Payments
- PROVENGE (Drug) $144,987
- Erleada (Drug) $62,384
- XTANDI (Drug) $45,395
- ERLEADA (Drug) $40,465
- Prolia (Biological) $35,501
- ELIGARD (Drug) $26,748
- Nubeqa (Drug) $22,188
- JELMYTO (Drug) $19,969
- XGEVA (Biological) $16,812
- KEYTRUDA (Biological) $16,315
- PLUVICTO (Drug) $15,104
- PROLARIS (Device) $9,454
- Xtandi (Drug) $9,276
- ORGOVYX (Drug) $8,668
- POSLUMA (Drug) $8,333
- CYSVIEW (Drug) $7,915
- ENZALUTAMIDE (Drug) $7,595
- PYLARIFY (Drug) $6,546
- Xofigo (Drug) $4,400
- LYNPARZA (Drug) $4,159
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in West Bloomfield
Gregory Oldford, Md, MD
Urology — Payments: $69,542
Urology $69,542
Jennifer Sobol, Do, DO
Urology — Payments: $34,022
Urology $34,022
Mitchell Hollander, Md, MD
Urology — Payments: $23,171
Urology $23,171
Dr. Brian Seifman, Md, MD
Urology — Payments: $17,856
Urology $17,856
Dr. James Relle, Md, MD
Urology — Payments: $6,881
Urology $6,881
Dr. Stephen Liroff, M.d, M.D
Urology — Payments: $2,858
Urology $2,858